NONPALPABLE STAGE T1C PROSTATE CANCER: PREDICTION OF INSIGNIFICANT DISEASE USING FREE/TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS AND NEEDLE BIOPSY FINDINGS
- 1 December 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (6 Part 2) , 2407-2411
- https://doi.org/10.1016/s0022-5347(01)62200-6
Abstract
Purpose: Approximately 25% of radical prostatectomies performed for stage T1c disease show potentially insignificant prostate cancer. We previously reported the use of serum prostate specif...Keywords
This publication has 25 references indexed in Scilit:
- THE USE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR STAGING CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisUrology, 1997
- Impalpable Invisible Stage T1c Prostate Cancer: Characteristics and Clinical Relevance in 100 Radical Prostatectomy Specimens-A Different ViewJournal of Urology, 1997
- Prospective characterization of pathological features of Prostatic Carcinomas Detected Via Serum Prostate Specific Antigen Based ScreeningJournal of Urology, 1996
- PSA‐detected prostate cancer: Contrasts with palpable diseaseJournal of Surgical Oncology, 1995
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- Biopsy proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level: Prevalence and pathologic characteristicsUrology, 1993
- Comparison of the pathologic features and DNA ploidy value of prostate cancers detectable by sonography and by palpationThe Prostate, 1993
- Accuracy of In-Vivo Assessment of Prostatic Volume by MRI and Transrectal UltrasonographyJournal of Computer Assisted Tomography, 1992